表紙
市場調査レポート

発熱性好中球減少症:世界の治験レビュー

Febrile Neutropenia Global Clinical Trials Review, H2, 2014

発行 GlobalData 商品コード 322166
出版日 ページ情報 英文 75 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.75円で換算しております。
Back to Top
発熱性好中球減少症:世界の治験レビュー Febrile Neutropenia Global Clinical Trials Review, H2, 2014
出版日: 2014年12月31日 ページ情報: 英文 75 Pages
概要

当レポートでは、発熱性好中球減少症の臨床試験に関連する基本情報やデータを提供しており、試験件数および被験者の募集状況、段階別の動向、臨床試験を実施している主な製薬企業および研究機関のプロファイルなどをまとめています。

イントロダクション

  • 発熱性好中球減少症
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要5ヶ国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中東・アフリカの主要国における治験件数
    • 中南米の主要5カ国における治験件数

G7諸国での治験件数:血液疾患の治験における発熱性好中球減少症の割合

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

E7諸国での治験件数:血液疾患の治験における発熱性好中球減少症の割合

E7諸国における段階別の治験件数

E7諸国での治験件数:進捗状況別

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

未完了の治験件数

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

発熱性好中球減少症治療薬の治験に携わっている主要企業

有望な薬剤

治験のプロファイル

  • 主要企業の治験の概要
    • BioGeneriX AG
    • Apotex, Inc.
    • Amgen Inc.
    • Zydus Cadila Healthcare Limited
    • Sandoz International GmbH
    • Pfizer Inc.
    • Johnson & Johnson
    • Hospira, Inc.
    • Dr. Reddy's Laboratories Limited
    • Coherus BioSciences, Inc.
  • 代表的な研究機関・病院の治験の概要
    • Iwate Medical University
    • Center for Supporting Hematology-Oncology Trials
    • Assistance Publique - Hopitaux de Paris
    • Lung Oncology Group in Kyushu
    • Japan 発熱性好中球減少症 Study Group
    • Rabin Medical Center
    • Wake Forest University
    • Yonsei University
    • 北海道大学医学部
    • Michigan State University

5つの代表的な治験のプロファイル

付録

目次
Product Code: GDHC2509CTIDB

GlobalData's clinical trial report, "Febrile Neutropenia Global Clinical Trials Review, H2, 2014" provides data on the Febrile Neutropenia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Febrile Neutropenia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Febrile Neutropenia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Febrile Neutropenia
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Febrile Neutropenia to Hematological Disorders Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Febrile Neutropenia to Hematological Disorders Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Febrile Neutropenia
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Febrile Neutropenia Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • BioGeneriX AG
      • Clinical Trial Overview of BioGeneriX AG
      • Apotex, Inc.
      • Clinical Trial Overview of Apotex, Inc.
      • Amgen Inc.
      • Clinical Trial Overview of Amgen Inc.
      • Zydus Cadila Healthcare Limited
      • Clinical Trial Overview of Zydus Cadila Healthcare Limited
      • Sandoz International GmbH
      • Clinical Trial Overview of Sandoz International GmbH
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Johnson & Johnson
      • Clinical Trial Overview of Johnson & Johnson
      • Hospira, Inc.
      • Clinical Trial Overview of Hospira, Inc.
      • Dr. Reddy's Laboratories Limited
      • Clinical Trial Overview of Dr. Reddy's Laboratories Limited
      • Coherus BioSciences, Inc.
      • Clinical Trial Overview of Coherus BioSciences, Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • Iwate Medical University
      • Clinical Trial Overview of Iwate Medical University
      • Center for Supporting Hematology-Oncology Trials
      • Clinical Trial Overview of Center for Supporting Hematology-Oncology Trials
      • Assistance Publique - Hopitaux de Paris
      • Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
      • Lung Oncology Group in Kyushu
      • Clinical Trial Overview of Lung Oncology Group in Kyushu
      • Japan Febrile Neutropenia Study Group
      • Clinical Trial Overview of Japan Febrile Neutropenia Study Group
      • Rabin Medical Center
      • Clinical Trial Overview of Rabin Medical Center
      • Wake Forest University
      • Clinical Trial Overview of Wake Forest University
      • Yonsei University
      • Clinical Trial Overview of Yonsei University
      • Hokkaido University School of Medicine
      • Clinical Trial Overview of Hokkaido University School of Medicine
      • Michigan State University
      • Clinical Trial Overview of Michigan State University
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Febrile Neutropenia Therapeutics, Global, Clinical Trials by Region, 2014*
  • Febrile Neutropenia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Febrile Neutropenia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Febrile Neutropenia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Febrile Neutropenia Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Febrile Neutropenia Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Febrile Neutropenia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Febrile Neutropenia Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014*
  • Proportion of Febrile Neutropenia to Hematological Disorders Clinical Trials, G7 Countries (%), 2014*
  • Febrile Neutropenia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Febrile Neutropenia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Febrile Neutropenia to Hematological Disorders Clinical Trials, E7 Countries (%), 2014*
  • Febrile Neutropenia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Febrile Neutropenia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Febrile Neutropenia Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Febrile Neutropenia Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Febrile Neutropenia Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Febrile Neutropenia Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Febrile Neutropenia Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Febrile Neutropenia Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Febrile Neutropenia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Febrile Neutropenia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Febrile Neutropenia Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Febrile Neutropenia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Febrile Neutropenia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Febrile Neutropenia Therapeutics Clinical Trials Market, Global, Clinical Trials by BioGeneriX AG, 2014*
  • Febrile Neutropenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Apotex, Inc., 2014*
  • Febrile Neutropenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014*
  • Febrile Neutropenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Zydus Cadila Healthcare Limited, 2014*
  • Febrile Neutropenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sandoz International GmbH, 2014*
  • Febrile Neutropenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Febrile Neutropenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014*
  • Febrile Neutropenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospira, Inc., 2014*
  • Febrile Neutropenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Dr. Reddy's Laboratories Limited, 2014*
  • Febrile Neutropenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Coherus BioSciences, Inc., 2014*
  • Febrile Neutropenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Iwate Medical University, 2014*
  • Febrile Neutropenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Center for Supporting Hematology-Oncology Trials, 2014*
  • Febrile Neutropenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014*
  • Febrile Neutropenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Lung Oncology Group in Kyushu, 2014*
  • Febrile Neutropenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Japan Febrile Neutropenia Study Group, 2014*
  • Febrile Neutropenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Rabin Medical Center, 2014*
  • Febrile Neutropenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest University, 2014*
  • Febrile Neutropenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Yonsei University, 2014*
  • Febrile Neutropenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Hokkaido University School of Medicine, 2014*
  • Febrile Neutropenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Michigan State University, 2014*

List of Figures

  • Febrile Neutropenia Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Febrile Neutropenia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Febrile Neutropenia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Febrile Neutropenia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Febrile Neutropenia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Febrile Neutropenia Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Febrile Neutropenia Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Febrile Neutropenia Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014*
  • Proportion of Febrile Neutropenia to Hematological Disorders Clinical Trials, G7 Countries (%), 2014*
  • Febrile Neutropenia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Febrile Neutropenia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Febrile Neutropenia to Hematological Disorders Clinical Trials, E7 Countries (%), 2014*
  • Febrile Neutropenia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Febrile Neutropenia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Febrile Neutropenia Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Febrile Neutropenia Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Febrile Neutropenia Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Febrile Neutropenia Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Febrile Neutropenia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Febrile Neutropenia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Febrile Neutropenia Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Febrile Neutropenia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Febrile Neutropenia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top